HonorStocks Biotech Gold Oil Mining China Asian MENU
Biotech Gold Oil Mining China Asian
Find Tomorrow's Winners Today

Stock technical analysis
Rating Flag Rating Flag Rating Flag Rating Flag Rating Flag
sell neutral buy
Ocugen, Inc. (OCGN)
6.13  -0.21  (-3.31%) 06-14 23:14
Open: 6.02 High: 6.5269
Pre.close: 6.34 Low: 5.96
Volume: 29,813,702 Ave vol: 65,194,649
52w High: 18.77 52w Low: 0.185
MA(50): 9.601 MA(200): 6.369
EPS: P/E Ratio: 0
Company profile
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Website: http://www.ocugen.com
Market Cap (M): 1,215
Shares Out (M): 198
Ocugen, Inc. engages in the development and commercialization of therapies for eye diseases. The company is headquartered in Malvern, Pennsylvania and currently employs 49 full-time employees. The firm offers a diversified ophthalmology portfolio that includes gene therapies, biologics, and small molecules and targets a range of retinal and ocular surface diseases. The firm is leveraging its modifier gene therapy platform to address genetically diverse inherited retinal disorders and dry age-related macular degeneration (AMD), based on nuclear hormone receptor genes NR2E3 (OCU400) and RORA (OCU410), respectively. The firm is also developing biologic therapies for wet-AMD, diabetic macular edema (DME) and diabetic retinopathy (OCU200), as well as for retinitis pigmentosa (OCU100).
Technical analysis
Overall: Underperform
MA: Bullish MACD: Bearish
KDJ: Bearish RSI: Bearish
Target 1: 10.64 Target 2: 12.91
Resist 1: 9.11 Resist 2: 11.05
Support 1: 5.96 Support 2: 4.96
Company key metrics
Revenue per Share: 0.0004
Net Income per Share: -0.1944
Cash per Share: 0.2142
Book Value per Share: 0.192
Price to Sales: 4661.143
Price to Book Value: 9.2183
Earnings Yield: -0.1098
Dividend Yield: 0
Debt to Equity: 0.0846
Debt to Assets: 0.2128
Financial analysis
Price to Book Value: Outperform
Return on Assets: Underperform
Return on Equity: Underperform
Discounted cash flow: Outperform
Price to Earnings: Underperform
Debt to Equity: Neutral
Stock Charts

HonorStocks, Find Tomorrow's Winners Today

©HonorStocks.com | U.S. stock markets, stock quotes and stock analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither HonorStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: IEX and Financial Modeling Prep

Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Google's use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.